Shares of Stem, Inc. (NYSE:STEM – Get Free Report) have received a consensus recommendation of “Hold” from the nine brokerages that are currently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $1.11.
A number of research analysts have commented on the stock. BMO Capital Markets cut their target price on shares of Stem from $0.50 to $0.40 and set a “market perform” rating on the stock in a research report on Wednesday, March 5th. Piper Sandler cut their price objective on shares of Stem from $1.50 to $0.30 and set a “neutral” rating on the stock in a research report on Friday, November 22nd. UBS Group lifted their price objective on shares of Stem from $0.60 to $0.65 and gave the stock a “buy” rating in a research report on Friday, March 7th. Finally, Roth Mkm lifted their price objective on shares of Stem from $0.35 to $0.40 and gave the stock a “neutral” rating in a research report on Wednesday, March 5th.
Read Our Latest Stock Report on Stem
Stem Stock Performance
Stem (NYSE:STEM – Get Free Report) last posted its earnings results on Tuesday, March 4th. The company reported ($0.12) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.04. The business had revenue of $55.83 million for the quarter, compared to the consensus estimate of $47.89 million. Stem had a negative net margin of 328.11% and a negative return on equity of 275.79%. During the same quarter last year, the firm posted ($0.21) EPS. Equities analysts expect that Stem will post -0.52 earnings per share for the current fiscal year.
Institutional Trading of Stem
Institutional investors have recently bought and sold shares of the stock. Barclays PLC boosted its stake in Stem by 213.1% in the 3rd quarter. Barclays PLC now owns 235,336 shares of the company’s stock worth $81,000 after purchasing an additional 160,165 shares in the last quarter. Geode Capital Management LLC boosted its stake in Stem by 4.8% in the 3rd quarter. Geode Capital Management LLC now owns 3,604,073 shares of the company’s stock worth $1,255,000 after purchasing an additional 166,002 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Stem by 77.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,406,080 shares of the company’s stock worth $837,000 after purchasing an additional 1,047,825 shares in the last quarter. Creative Planning boosted its stake in Stem by 177.1% in the 3rd quarter. Creative Planning now owns 123,521 shares of the company’s stock worth $43,000 after purchasing an additional 78,940 shares in the last quarter. Finally, Aries Wealth Management boosted its stake in Stem by 100.0% in the 4th quarter. Aries Wealth Management now owns 50,000 shares of the company’s stock worth $30,000 after purchasing an additional 25,000 shares in the last quarter. 61.63% of the stock is currently owned by institutional investors and hedge funds.
About Stem
Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.
See Also
- Five stocks we like better than Stem
- Dividend Payout Ratio Calculator
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- 3 Grocery Stocks That Are Proving They Are Still Essential
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.